Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Inaccurate MDS Medication Coding for Psychotropic and Antiplatelet Drugs

Hobbs, New Mexico Survey Completed on 01-30-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure an accurate Minimum Data Set (MDS) assessment for one resident when required medication use was not correctly documented. Record review showed that this resident had multiple active physician orders, including Zoloft 100 mg daily for depression, Depakote Sprinkles 125 mg two capsules twice daily for dementia with behaviors, Gabapentin 300 mg twice daily for anxiety, Aspirin 81 mg daily for prophylactic measures related to a history of stroke, and Clopidogrel 75 mg daily for prophylactic measures related to a history of stroke. These orders established that the resident was receiving antidepressant, anticonvulsant, and antiplatelet medications during the assessment period. Despite these active medication orders, the resident’s MDS, in Section N – Medications, indicated that the resident did not take antidepressant, anticonvulsant, or antiplatelet medications. During an interview, the MDS coordinator confirmed that the assessment for this resident was inaccurate and acknowledged that it should have reflected the use of antidepressant, anticonvulsant, and antiplatelet medications but did not.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙